On November 7, 2025 at BIO-Europe, Insilico Medicine disclosed eight oral small-molecule programs for cardiometabolic diseases discovered with its Pharma.AI platform. The portfolio spans lead …
Read More
Lately, bioprinting is shifting from proof-of-concept prints to regulated workflows and early clinical use. In July 2022 in San Antonio, Texas, surgeons performed the first …
Read More
Manifold Bio, a Boston-based platform therapeutics company, announced a strategic collaboration and license agreement with Roche to develop several next-generation blood-brain barrier (BBB) shuttles intended …
Read More
Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research and business potential in the …
Read More
Rare diseases sit at an uncomfortable scale: about 30 million people in the U.S., roughly >300 million worldwide. According to NIH, there are an estimated …
Read More
Flatiron Health has launched six new hematology datasets built using AI and large language models (LLMs), unlocking longitudinal clinical data for 505,000 patients with blood …
Read More
